Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 3/2020

04.09.2019 | Original Research

Effects of Curcumin and Silymarin on the Shigella dysenteriae and Campylobacter jejuni In vitro

verfasst von: Sawsan Mohammed Kareem, Suhad Saad Mahmood, Nada KhazalKadhim Hindi

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

Antimicrobial properties of silymarin and curcumin have been assessed against several infectious agents. The aim of this study was to investigate the anti-apoptotic and antibacterial effects of both compounds on the expression of genes among Shigella dysenteriae ATCC 12022 and Campylobacter jejuni subsp. jejuni strain ATCC 33560 standard strains.

Methods

S. dysenteriae and C. jejuni standard strains were prepared from reference laboratory. Additionally, two clinical multidrug-resistant (MDR) isolates were adopted. Silymarin and curcumin stocks were purchased from Sigma Corporation (USA), and after preparation of dilutions (0.5–512 μg/ml), the minimum inhibitory concentration (MIC) and minimum bactericidal concentrations (MBC) were determined. Furthermore, the effect of 100 μg/ml of each compound was also evaluated on the expression of two gyrB and 16S rRNA housekeeping genes by quantitative real-time PCR (qRT-PCR).

Results

Silymarin MIC and MBC were 512 μg/ml and > 512 μg/ml against S. dysenteriae and > 512μg/ml against C. jejuni standard strains, respectively. Moreover, curcumin MIC and MBC concentrations were 256 μg/ml and 512 μg/ml, respectively for ATCC strains. Silymarin down-expressed the expression of gyrB gene in S. dysenteriae and gyrB and 16srRNA gene in C. jejuni significantly (p < 0.05) compared with unexposed strains. In addition, curcumin could down-express the both gyrB and 16S rRNA genes in both strains significantly (p < 0.05). For two MDR clinical isolates, both MIC and MBC of compounds were > 512 μg/ml. Addition of 100 μg/ml curcumin and silymarin to ampicillin (10 μg/ml) lowered the MIC of MDR S. dysenteriae to 256 μg/ml and 512 μg/ml, respectively. However, no MIC change was observed with regard to C. jejuni.

Conclusion

In this study, curcumin and silymarin could inhibit the growth of S. dysenteriae and C. jejuni and 100 μg/ml sub-MIC levels exhibited the suppression of housekeeping genes. Combating pathogenic bacteria by compounds alternative to antibiotics in the era of antibiotic resistance is a proper strategy, though more studies using combinations of them are needed.
Literatur
1.
2.
Zurück zum Zitat Ferreccio C, Prado V, Ojeda A, Cayyazo M, Abrego P, Guers L, et al. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. Am J Epidemiol. 1991;134:614–27.CrossRef Ferreccio C, Prado V, Ojeda A, Cayyazo M, Abrego P, Guers L, et al. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. Am J Epidemiol. 1991;134:614–27.CrossRef
3.
Zurück zum Zitat Livio S, Strockbine NA, Panchalingam S, Tennant SM, Barry EM, Marohn ME, et al. Shigella isolates from the global enteric multicenter study inform vaccine development. Clin Infect Dis. 2014;59:933–41.CrossRef Livio S, Strockbine NA, Panchalingam S, Tennant SM, Barry EM, Marohn ME, et al. Shigella isolates from the global enteric multicenter study inform vaccine development. Clin Infect Dis. 2014;59:933–41.CrossRef
4.
Zurück zum Zitat Noriega FR, Liao FM, Maneval DR, Ren S, Formal SB, Levine MM. Strategy for cross-protection among Shigella flexneri serotypes. Infect Immun. 1999;67:782–8.CrossRef Noriega FR, Liao FM, Maneval DR, Ren S, Formal SB, Levine MM. Strategy for cross-protection among Shigella flexneri serotypes. Infect Immun. 1999;67:782–8.CrossRef
5.
Zurück zum Zitat Bardhan P, Faruque A, Naheed A, Sack DA. Decreasing shigellosis-related deaths without Shigella spp.–specific interventions, Asia. Emerg Infect Dis. 2010;16:1718–23.CrossRef Bardhan P, Faruque A, Naheed A, Sack DA. Decreasing shigellosis-related deaths without Shigella spp.–specific interventions, Asia. Emerg Infect Dis. 2010;16:1718–23.CrossRef
6.
Zurück zum Zitat Crump JA, Mintz ED. Global trends in typhoid and paratyphoid fever. Clin Infect Dis. 2010;50:241–6.CrossRef Crump JA, Mintz ED. Global trends in typhoid and paratyphoid fever. Clin Infect Dis. 2010;50:241–6.CrossRef
7.
Zurück zum Zitat Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AK. Shigellosis. The Lancet. 2018;391(10122):801–12. Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AK. Shigellosis. The Lancet. 2018;391(10122):801–12.
8.
Zurück zum Zitat Rohde A, Hammerl JA, Boone I, Jansen W, Fohler S, Klein G, Dieckmann R, Al Dahouk S. Overview of validated alternative methods for the detection of foodborne bacterial pathogens. Trend Food Sci Technol. 2017;62:113–8. Rohde A, Hammerl JA, Boone I, Jansen W, Fohler S, Klein G, Dieckmann R, Al Dahouk S. Overview of validated alternative methods for the detection of foodborne bacterial pathogens. Trend Food Sci Technol. 2017;62:113–8.
9.
Zurück zum Zitat Samadi Andzagi G, Fardin M. Investigation of Compositions and Effects of Local Herbal Silybum marianum and Foeniculum vulgare extractions on Hospital Acquired Infections (HAI) and Cell Line of liver Cancer (HepG2) by MTT assays. J Herb Drug (An International Journal on Medicinal Herbs). 2016;7(4):275–82. Samadi Andzagi G, Fardin M. Investigation of Compositions and Effects of Local Herbal Silybum marianum and Foeniculum vulgare extractions on Hospital Acquired Infections (HAI) and Cell Line of liver Cancer (HepG2) by MTT assays. J Herb Drug (An International Journal on Medicinal Herbs). 2016;7(4):275–82.
10.
Zurück zum Zitat Bessam F, Mehdadi Z. Evaluation of the antibacterial and antifongigal activity of different extract of Flavonoïques Silybum marianum L. Adv Environ Biol. 2014;8:1–9. Bessam F, Mehdadi Z. Evaluation of the antibacterial and antifongigal activity of different extract of Flavonoïques Silybum marianum L. Adv Environ Biol. 2014;8:1–9.
11.
Zurück zum Zitat Shah SMM, Khan FA, Shah SMH, Chishti KA, Pirzada S, Khan MA, et al. Evaluation of phytochemicals and antimicrobial activity of white and blue capitulum and whole plant of Silybum marianum. World Appl Sci J. 2011;12:1139–44. Shah SMM, Khan FA, Shah SMH, Chishti KA, Pirzada S, Khan MA, et al. Evaluation of phytochemicals and antimicrobial activity of white and blue capitulum and whole plant of Silybum marianum. World Appl Sci J. 2011;12:1139–44.
12.
Zurück zum Zitat Vargas-Mendoza N, Madrigal-Santillán E, Morales-González Á, Esquivel-Soto J, Esquivel-Chirino C, González-Rubio MG-L, et al. Hepatoprotective effect of silymarin. World J Hepatol. 2014;6:144–9.CrossRef Vargas-Mendoza N, Madrigal-Santillán E, Morales-González Á, Esquivel-Soto J, Esquivel-Chirino C, González-Rubio MG-L, et al. Hepatoprotective effect of silymarin. World J Hepatol. 2014;6:144–9.CrossRef
13.
Zurück zum Zitat Krausz AE, Adler BL, Cabral V, Navati M, Doerner J, Charafeddine RA, et al. Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent. Nanomedicine. 2015;11:195–206.CrossRef Krausz AE, Adler BL, Cabral V, Navati M, Doerner J, Charafeddine RA, et al. Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent. Nanomedicine. 2015;11:195–206.CrossRef
14.
Zurück zum Zitat Najafi S, Khayamzadeh M, Paknejad M, Poursepanj G, Fard MJK, Bahador A. An in vitro comparison of antimicrobial effects of curcumin-based photodynamic therapy and chlorhexidine, on Aggregatibacter actinomycetemcomitans. J Lasers Med Sci. 2016;7:21–5.CrossRef Najafi S, Khayamzadeh M, Paknejad M, Poursepanj G, Fard MJK, Bahador A. An in vitro comparison of antimicrobial effects of curcumin-based photodynamic therapy and chlorhexidine, on Aggregatibacter actinomycetemcomitans. J Lasers Med Sci. 2016;7:21–5.CrossRef
15.
Zurück zum Zitat Ungphaiboon S, Supavita T, Singchangchai P, Sungkarak S, Rattanasuwan P, Itharat A. Study on antioxidant and antimicrobial activities of turmeric clear liquid soap for wound treatment of HIV patients. Songklanakarin J Sci Technol. 2005;27:269–578. Ungphaiboon S, Supavita T, Singchangchai P, Sungkarak S, Rattanasuwan P, Itharat A. Study on antioxidant and antimicrobial activities of turmeric clear liquid soap for wound treatment of HIV patients. Songklanakarin J Sci Technol. 2005;27:269–578.
16.
Zurück zum Zitat Varaprasad K, Vimala K, Ravindra S, Reddy NN, Reddy GVS, Raju KM. Fabrication of silver nanocomposite films impregnated with curcumin for superior antibacterial applications. J Mater Sci Mater Med. 2011;22:1863–72.CrossRef Varaprasad K, Vimala K, Ravindra S, Reddy NN, Reddy GVS, Raju KM. Fabrication of silver nanocomposite films impregnated with curcumin for superior antibacterial applications. J Mater Sci Mater Med. 2011;22:1863–72.CrossRef
17.
Zurück zum Zitat Lawhavinit O-a, Kongkathip N, Kongkathip B. Antimicrobial activity of curcuminoids from Curcuma longa L. on pathogenic bacteria of shrimp and chicken. Kasetsart J (Nat Sci). 2010;44:364–71. Lawhavinit O-a, Kongkathip N, Kongkathip B. Antimicrobial activity of curcuminoids from Curcuma longa L. on pathogenic bacteria of shrimp and chicken. Kasetsart J (Nat Sci). 2010;44:364–71.
18.
Zurück zum Zitat Hosny I, El Kholy W, Murad H, El Dairouty R. Antimicrobial activity of curcumin upon pathogenic microorganisms during manufacture and storage of a novel style cheese ‘Karishcum’. J Am Sci. 2011;7:611–8. Hosny I, El Kholy W, Murad H, El Dairouty R. Antimicrobial activity of curcumin upon pathogenic microorganisms during manufacture and storage of a novel style cheese ‘Karishcum’. J Am Sci. 2011;7:611–8.
19.
Zurück zum Zitat Talamantes-Becerra B, Carling J, Kennedy K, Gahan ME, Georges A. Identification of bacterial isolates from a public hospital in Australia using complexity-reduced genotyping. J Microbiol Method. 2019;160:11–9. Talamantes-Becerra B, Carling J, Kennedy K, Gahan ME, Georges A. Identification of bacterial isolates from a public hospital in Australia using complexity-reduced genotyping. J Microbiol Method. 2019;160:11–9.
20.
Zurück zum Zitat Evren E, Yurtcu E. In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin. Folia Microbiol. 2015;60:351–6.CrossRef Evren E, Yurtcu E. In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin. Folia Microbiol. 2015;60:351–6.CrossRef
21.
Zurück zum Zitat Surai PF. Silymarin as a natural antioxidant: an overview of the current evidence and perspectives. Antioxidants. 2015;4:204–47.CrossRef Surai PF. Silymarin as a natural antioxidant: an overview of the current evidence and perspectives. Antioxidants. 2015;4:204–47.CrossRef
22.
Zurück zum Zitat Lahlah ZF, Meziani M, Maza A. Silymarin natural antimicrobial agent extracted from Silybum marianum. J Acad. 2012;2:164–9. Lahlah ZF, Meziani M, Maza A. Silymarin natural antimicrobial agent extracted from Silybum marianum. J Acad. 2012;2:164–9.
23.
Zurück zum Zitat Lee DG, Kim HK, Park Y, Park S-C, Woo E-R, Jeong HG, et al. Gram-positive bacteria specific properties of silybin derived from Silybum marianum. Arch Pharm Res. 2003;26:597–600.CrossRef Lee DG, Kim HK, Park Y, Park S-C, Woo E-R, Jeong HG, et al. Gram-positive bacteria specific properties of silybin derived from Silybum marianum. Arch Pharm Res. 2003;26:597–600.CrossRef
24.
Zurück zum Zitat Wen Z, Dumas TE, Schrieber SJ, Hawke RL, Fried MW, Smith PC. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metab Dispos. 2008;36:65–72.CrossRef Wen Z, Dumas TE, Schrieber SJ, Hawke RL, Fried MW, Smith PC. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metab Dispos. 2008;36:65–72.CrossRef
25.
Zurück zum Zitat Koosirirat C, Linpisarn S, Changsom D, Chawansuntati K, Wipasa J. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. Int Immunopharmacol. 2010;10:815–8.CrossRef Koosirirat C, Linpisarn S, Changsom D, Chawansuntati K, Wipasa J. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. Int Immunopharmacol. 2010;10:815–8.CrossRef
26.
Zurück zum Zitat Sintara K, Thong-Ngam D, Patumraj S, Klaikeaw N, Chatsuwan T. Curcumin suppresses gastric NF-κB activation and macromolecular leakage in Helicobacter pylori-infected rats. World J Gastroenterol: WJG. 2010;16:4039.CrossRef Sintara K, Thong-Ngam D, Patumraj S, Klaikeaw N, Chatsuwan T. Curcumin suppresses gastric NF-κB activation and macromolecular leakage in Helicobacter pylori-infected rats. World J Gastroenterol: WJG. 2010;16:4039.CrossRef
27.
Zurück zum Zitat Gunes H, Gulen D, Mutlu R, Gumus A, Tas T, Topkaya AE. Antibacterial effects of curcumin: an in vitro minimum inhibitory concentration study. Toxicol Ind Health. 2016;32:246–50.CrossRef Gunes H, Gulen D, Mutlu R, Gumus A, Tas T, Topkaya AE. Antibacterial effects of curcumin: an in vitro minimum inhibitory concentration study. Toxicol Ind Health. 2016;32:246–50.CrossRef
Metadaten
Titel
Effects of Curcumin and Silymarin on the Shigella dysenteriae and Campylobacter jejuni In vitro
verfasst von
Sawsan Mohammed Kareem
Suhad Saad Mahmood
Nada KhazalKadhim Hindi
Publikationsdatum
04.09.2019
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 3/2020
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-019-00301-1

Weitere Artikel der Ausgabe 3/2020

Journal of Gastrointestinal Cancer 3/2020 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.